Reporting owner · Q3 2026 · CIK 2136241

Elrifi Ivor: insider trades.

Elrifi Ivor reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 3 open-market purchases ($986K) and 0 sales, across 1 company.

Transactions
4
Purchases (P)
3
Sales (S)
0
Companies
1
Name as filed
Elrifi Ivor

Companies

CompanyRelationshipTransactions
Tiziana Life Sciences Ltd (TLSA)Officer · Chief Executive Officer4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-15Tiziana Life Sciences LtdM1,050,000—5,843,684Form 4
2026-08-05Tiziana Life Sciences LtdP237,616$14,793,684Form 4
2026-08-04Tiziana Life Sciences LtdP83,807$0.974,556,068Form 4
2026-08-03Tiziana Life Sciences LtdP667,000$14,472,261Form 4

Questions

What stock did Elrifi Ivor buy or sell?

Elrifi Ivor reported 4 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 3 open-market purchases ($986K) and 0 sales, across 1 company.

Is Elrifi Ivor the same person as other filers with this name?

This page covers SEC CIK 2136241 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/elrifi-ivor-2136241.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.